Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Royal Academy of Engineering has announced the finalists for the 2025 MacRobert Award, the longest running and most prestigious prize for UK engineering innovation.

OrganOx metra Flight

The MacRobert Award is run by the Royal Academy of Engineering and recognises engineering teams that demonstrate outstanding innovation, tangible societal benefit and proven commerciality within the UK engineering sector.

The three finalists for the 2025 MacRobert Award include OrganOx (Oxford) for creating a transportable normothermic organ perfusion device, which is a world first originating from research at the University of Oxford.

OrganOx was spun out of the University of Oxford in 2008 by biomedical engineer Professor Constantin Coussios OBE FREng FMedSci and transplant surgeon Professor Peter Friend FMedSci FRCS to translate an innovative technology capable of keeping organs alive and functioning outside the body for several days. Applied today commercially to livers and investigationally to kidneys, OrganOx technology makes it possible to preserve organs for longer than ever before, test them objectively before deciding whether to transplant them, and potentially even use a second human or pig organ outside the body to enable the patient’s own liver to recover from injury and thus avoid a transplant altogether.  

The Vice-Chancellor of the University of Oxford, Professor Irene Tracey CBE FRS, commented: 'OrganOx exemplifies Oxford’s knack for combining and effectively translating technological innovation and the very best of medical science for patient and societal impact. Nurtured by cross-disciplinary research and collaboration, it is the first of many medical technologies and biotechnologies presently emerging from the University’s world-leading innovation and translational ecosystem that are transforming the future of healthcare.'

 

Read the full story on the University of Oxford website

Similar stories

Breakthrough in non-invasive liver testing

Two major international studies, including an imaging study led by researchers from the Radcliffe Department of Medicine, have provided new evidence on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, potentially reducing reliance on liver biopsy.

Researchers from the Nuffield Department of Primary Care Health Sciences contribute to parliamentary calls for overhaul of obesity care

Research from the Health Behaviors team has informed a series of parliamentary reports calling for urgent action to tackle obesity in England.

Oxford University invites 100,000 people to take part in a major study of plant-based diets

Researchers at the Nuffield Department of Population Health have launched a major new study designed to generate the most up-to-date picture of different diets in the UK, including plant-based diets, and how they affect long-term health and wellbeing.

Look beyond my skin: your psoriasis could help us understand who develops psoriatic arthritis

Adults with psoriasis across Europe are invited to take part in an online study aiming to identify who is at risk of developing psoriatic arthritis.

Professor Matthew Wood receives BioUK Special Recognition Award 2026

Professor Matthew Wood, Director and Chief Scientific Officer of the Oxford-Harrington Rare Disease Centre (OHC), has received BioUK’s Special Recognition Award 2026 for his contribution to rare disease research, therapeutic development and the wider life sciences sector.

University of Oxford and BIIE launch collaboration in translational immune engineering

Researchers from the Department of Paediatrics at the University of Oxford and the Botnar Institute of Immune Engineering (BIIE) came together in Oxford last week for the inaugural scientific meeting of the new Basel–Oxford Centre for Translational Immune Engineering for Child and Adolescent Health (CTIE).